Literature DB >> 25474035

Notes from the field: Transmission of chikungunya virus in the continental United States--Florida, 2014.

Katherine Kendrick, Danielle Stanek, Carina Blackmore.   

Abstract

On June 27, 2014, the Florida Department of Health in Miami-Dade County was notified by the Florida Poison Information Center Network of a patient with travel to Southeast Asia who was suspected of having chikungunya virus infection. After further investigation and additional testing, it was determined that the patient had not recently traveled to an endemic area, and this case was confirmed as the first locally acquired chikungunya case in the continental United States. Since the first case of locally acquired chikungunya virus infection in the Americas was reported on the Caribbean island of St. Martin in December 2013, the United States has seen an increase in chikungunya cases among travelers returning from areas where chikungunya has become endemic, particularly the Caribbean and South America. Compared with other states, Florida has seen an especially large number of chikungunya fever cases. During January 1-October 14, 2014, a total of 272 imported cases were reported in Florida, compared with 1,110 reported in the other 47 contiguous states. In addition, 11 locally acquired chikungunya cases have been identified. The recent spread of the virus and the presence of competent mosquito vectors provide the conditions for transmission of chikungunya virus in Florida.

Entities:  

Mesh:

Year:  2014        PMID: 25474035      PMCID: PMC4584604     

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


On June 27, 2014, the Florida Department of Health in Miami-Dade County was notified by the Florida Poison Information Center Network of a patient with travel to Southeast Asia who was suspected of having chikungunya virus infection. After further investigation and additional testing, it was determined that the patient had not recently traveled to an endemic area, and this case was confirmed as the first locally acquired chikungunya case in the continental United States. Since the first case of locally acquired chikungunya virus infection in the Americas was reported on the Caribbean island of St. Martin in December 2013, the United States has seen an increase in chikungunya cases among travelers returning from areas where chikungunya has become endemic, particularly the Caribbean and South America (1). Compared with other states, Florida has seen an especially large number of chikungunya fever cases. During January 1–October 14, 2014, a total of 272 imported cases were reported in Florida, compared with 1,110 reported in the other 47 contiguous states. In addition, 11 locally acquired chikungunya cases have been identified. The recent spread of the virus and the presence of competent mosquito vectors provide the conditions for transmission of chikungunya virus in Florida (2,3). Beginning with the first report on June 27, a total of 11 autochthonous chikungunya disease cases in Florida have been reported from four counties: two in Miami-Dade, four in Palm Beach, four in St. Lucie, and one in Broward. All four counties are in South Florida, and three of them (Miami-Dade, Palm Beach, and Broward counties) have reported 131 (48%) of the 272 imported cases in Florida. All 11 locally acquired cases were laboratory-confirmed, seven by polymerase chain reaction. Two of the patients in St. Lucie County live within 1,500 feet (457 meters) of each other, and the cases appear to be linked because of their proximity in space and time; the source is unknown. Of the persons with locally acquired cases, eight (73%) of 11 were female, eight (80%) of 10 were white, and nine (90%) of 10 were non-Hispanic. Median age of the patients was 43 years (range = 29–78 years). In comparison, of the 272 persons with imported cases, 155 (57%) of 272 were female, 113 (42%) of 267 were white, and 141 (53%) of 265 were non-Hispanic; median age was 48 years (range = 0–88 years). Among imported cases, the most common country of exposure was Haiti (38%), followed by the Dominican Republic (30%); the most common reason for travel was to visit friends and relatives (72%). Surveillance related to local introductions of chikungunya virus included 50–100 meter cluster investigations around a patient’s residence, enhanced syndromic surveillance, and medical record review. Awareness was increased through media coverage, reverse 911 dialing, and targeted mailings. For more than half of the cases, both locally acquired and imported, local mosquito control workers were notified and deployed to patients’ residences before or on the same day the counties received the positive laboratory test results. Based on U.S. experiences with dengue virus, which shares the same vectors as chikungunya virus, awareness of the situation in Florida can help inform surveillance activities and control efforts throughout the United States. Because no vaccine exists to prevent chikungunya fever, the mainstay of prevention is avoiding bites of the mosquitoes that transmit the virus, mostly during daylight hours. The Florida Department of Health and CDC recommend using air conditioning or screens to keep mosquitoes outside, emptying standing water from containers such as flowerpots and buckets where mosquitoes might breed, wearing long-sleeved shirts and long pants, and using insect repellents (1).
  1 in total

1.  Notes from the field: chikungunya virus spreads in the Americas - Caribbean and South America, 2013-2014.

Authors:  Marc Fischer; J Erin Staples
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-06-06       Impact factor: 17.586

  1 in total
  46 in total

1.  Chikungunya Virus Disease among Travelers-United States, 2014-2016.

Authors:  Nicole P Lindsey; J Erin Staples; Marc Fischer
Journal:  Am J Trop Med Hyg       Date:  2018-01-01       Impact factor: 2.345

2.  A Case of Diabetic Ketoacidosis Following Chikungunya Virus Infection.

Authors:  Illya Tolokh; Timothy Laux; Daniel Kim
Journal:  Am J Trop Med Hyg       Date:  2015-06-01       Impact factor: 2.345

3.  Identification and Characterization of Sindbis Virus RNA-Host Protein Interactions.

Authors:  Autumn T LaPointe; Natasha N Gebhart; Megan E Meller; Richard W Hardy; Kevin J Sokoloski
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

Review 4.  The burden of dengue and chikungunya worldwide: implications for the southern United States and California.

Authors:  Anthony C Fredericks; Ana Fernandez-Sesma
Journal:  Ann Glob Health       Date:  2014 Nov-Dec       Impact factor: 2.462

5.  Using Google Trends to Predict Pediatric Respiratory Syncytial Virus Encounters at a Major Health Care System.

Authors:  Matthew G Crowson; David Witsell; Antoine Eskander
Journal:  J Med Syst       Date:  2020-01-30       Impact factor: 4.460

Review 6.  Emerging and re-emerging infectious diseases in Japan: epidemiology and infection prevention measures.

Authors:  Satoshi Kutsuna
Journal:  Glob Health Med       Date:  2019-12-31

Review 7.  Immune-Mediated Protection and Pathogenesis of Chikungunya Virus.

Authors:  Julie M Fox; Michael S Diamond
Journal:  J Immunol       Date:  2016-12-01       Impact factor: 5.422

8.  Baseline Susceptibility Status of Florida Populations of Aedes aegypti (Diptera: Culicidae) and Aedes albopictus.

Authors:  Casey Parker; Daviela Ramirez; Carol Thomas; C Roxanne Connelly
Journal:  J Med Entomol       Date:  2020-09-07       Impact factor: 2.278

9.  The Need for a National Strategy to Address Vector-Borne Disease Threats in the United States.

Authors:  Charles B Beard; Susanna N Visser; Lyle R Petersen
Journal:  J Med Entomol       Date:  2019-09-03       Impact factor: 2.278

10.  A comparison of compliance rates with anti-vectorial protective measures during travel to regions with dengue or chikungunya activity, and regions endemic for Plasmodium falciparum malaria.

Authors:  Tahaniyat Lalani; Heather Yun; David Tribble; Anuradha Ganesan; Anjali Kunz; Mary Fairchok; Elizabeth Schnaubelt; Jamie Fraser; Indrani Mitra; Karl C Kronmann; Timothy Burgess; Robert G Deiss; Mark S Riddle; Mark D Johnson
Journal:  J Travel Med       Date:  2016-07-04       Impact factor: 8.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.